SpeeDx Pty, Ltd. and MolGen announced the signing of an agreement to collaborate on supply and distribution of clinical diagnostics products and instrumentation across Europe and Asia Pacific. The partnership links specimen handling, nucleic acid extraction, assay set-up, amplification, and results reporting in a seamless integration of the companies technologies...
In the pharmaceutical industry, the trend is to move from conventional batch manufacturing to continuous manufacturing processes. The challenges for such change are numerous, but many papers are published to solve those issues and improve production. This is the case of the paper published by Carl Allenspach from Bristol-Myers Squibb (International Journal of Pharmaceutics 596 (2021)....
Owlstone Medical (or the “Company”), the global leader in Breath Biopsy® for applications in early disease detection and precision medicine, has announced the publication of a peer-reviewed study in Nature Scientific Reports. The paper investigates the performance of filters embedded in face masks for supporting the detection of SARS-CoV-2 as an alternative to nasopharyngeal swabs (NPS)...
Merck, a leading science and technology company, has announced the winners of this year’s Future Insight Prize. The € 1 million prize in the category of “Food Generation” was awarded during the Future Insight Days in Darmstadt, Germany, to Ting Lu, Professor of Bioengineering at the University of Illinois Urbana-Champaign, USA, and Stephen Techtmann, Associate Professor of Biological Sciences at Michigan Technological University, USA....
The race is on in the diagnostics industry to develop a device that instantly detects coronavirus for use in large public spaces and airports, according to one of the UK’s top medical technology recruiters. Ivor Campbell, chief executive of Snedden Campbell, said the biggest companies are chasing the ‘holy grail’ of a rapid-test, biosensing device – similar to that used to test blood sugar levels in diabetic patients – that will identify whether a patient has Covid within a matter of seconds...
Cerno Bioscience, in collaboration with XenoBiotic Labs*, has recently published an article in the peer reviewed journal "Rapid Communications in Mass Spectrometry" which demonstrates reliable and accurate quantitation of both cold and hot labeled compounds down to 0.5%. This robust method was tested on both simple and complex systems containing as many as 6 separate labeling sites and is capable of quantifying from...
MIMETAS, a leader in organ-on-chip-based disease models and technology, and Roche, a world-leading pharmaceutical company, announce that they have entered into a collaboration to develop human disease models to characterize novel compounds in inflammatory bowel disease (IBD) and hepatitis B virus infections (HBV). Under the terms of the agreement, MIMETAS is eligible to receive an upfront payment and milestone payments from Roche...
The Center of Excellence in Clinical Metabolomics, based on the UC Davis Sacramento campus, will enable targeted and untargeted metabolic profiling for large-scale population-based cohorts across translational research and precision medicine. The Center will develop standardized processes for the research community, including end-to-end metabolic profiling workflows; optimized liquid chromatography-mass spectrometry (LC-MS) methods, protocols...
Tumor fragments in the lab are able to predict whether the corresponding real-life patients will benefit from immunotherapy. “We’ve solved a major problem many scientists had been facing: preserving a tumors original composition and structure outside of the patient in the lab”, says cancer researcher Daniela Thommen from the Netherlands Cancer Institute. On 8 July, the results of her study are published in Nature Medicine....
VectorBuilder – a global leader in vector design, optimization and GMP manufacturing – has formed a worldwide strategic partnership with Univercells Technologies, a provider of novel biomanufacturing technologies for flexible and scalable viral vector production. VectorBuilder’s manufacturing center in Guangzhou, China, will work with Univercells Technologies to develop and optimize platform processes for the production of custom viral vectors for cell and gene therapies, as well as vaccine applications....
Illumina, Inc. has announced an agreement with the Belgian Genetic Centers to evaluate whole-genome sequencing (WGS) for the diagnosis of patients with intellectual disabilities (ID) and/or developmental disorders (DD) in routine care. The study, run by the Belgian Resolve Rare Diseases group (BeSolveRD), will also assess the health economic impact of WGS versus current standards of care....
Sinocompound Catalysts Co., Ltd has launched a new video series sharing its specialist catalyst expertise adding to its bank of educational materials. Titled ‘The essentials in a synthetic chemist’s toolbox’, the series was the idea and work of technical advisor, Dr Carin Seechurn. As a global provider of advanced homogeneous catalysts and ligands for pharmaceutical and fine chemical applications, Sinocompound is ideally placed to guide scientists through some of the challenges they may need to navigate...
A new study could lead to improved decision making in assigning treatments for children with the aggressive cancer rhabdomyosarcoma after revealing key genetic changes underlying development of the disease. In the largest and most comprehensive study of rhabdomyosarcoma to date, scientists found that specific genetic changes in tumours are linked to aggressiveness, early age of onset and location in the body....
The Government Chemist (GC), hosted at LGC, has published the results of a recent international ring trial on the determination of cannabidiol (CBD) - an uncontrolled cannabinoid- and controlled cannabinoids in consumer products such as food and cosmetics. Consumer CBD products have entered the UK market rapidly in a variety of forms, including food and cosmetics. CBD when used as an ingredient in food or cosmetic products must currently be free from controlled cannabinoids....
AMSBIO invite the global research community to the 2021 annual meeting of the ISSCR, the leading professional organization of stem cell scientists, to discover how iPSCs and organoids can be used in COVID-19 drug discovery research. At this virtual meeting - Dr. Kazuo Takayama from the renowned Center for iPS Cell Research and application (CiRA) at Kyoto University will be giving a unique insight into his recent pioneering research...
The Maulide Group at the University of Vienna (Austria) describe how a devastating water leak in a nearby chemistry laboratory prompted them to search for alternative, water-free, options to Liebig condensers for refluxing. The group teamed up with Green Labs Austria to see if they could provide and share a more sustainable solution to water cooled refluxing in the lab....
The moisture determination of liquid soap is essential to ensure a product of the highest quality. If the moisture content is too high or too low, this can result in a low quality product and wastage can occur. In this application note we determine the moisture of liquid soap using Precisa’s XM60/EM120 Halogen moisture analyser...
In 2021, Eppendorf AG, the Hamburg life sciences company, is presenting its highly prestigious research prize for the 26th time. The independent Eppendorf Award Jury chaired by Prof. Reinhard Jahn announced Dr. Tanmay Bharat, Sir William Dunn School of Pathology, University of Oxford, United Kingdom as the winner of the Eppendorf Award for European Investigators 2021....
108Labs, a biotechnology and software company with a mission to invent disruptive cellular agriculture projects, has announced their focus on building and programming the world’s first autonomous Cellufacturing® facility and artificial intelligence platform for the production of cell-cultured human milk, in the birthplace of biosynthetic human milk, Hillsborough, North Carolina....
Binding Site is pleased to announce that the ground-breaking iStopMM (Iceland Screens, Treats or Prevents Multiple Myeloma) study has reached an important milestone, with the publication of a paper outlining the design and recruitment of this population-based screening study. The large-scale study – which includes over 80,000 individuals, more than half of the eligible population of Iceland...
Leading Drug Discovery Contract Research Organisation Sygnature Discovery has announced the set-up of a state-of-the-art Early Candidate Developability Screening Group. Located at its headquarters in Nottingham, UK, the new service line will expand on the company’s offerings to customers by bridging into formal preclinical drug development and paving the way for clinical trials...
Scientists have identified a new class of targeted cancer drugs that offer the potential to treat patients whose tumours have faulty copies of the BRCA cancer genes. The drugs, known as POLQ inhibitors, specifically kill cancer cells with mutations in the BRCA genes while leaving healthy cells unharmed. And crucially, they can kill cancer cells that have become resistant to PARP inhibitors – an existing treatment for patients with BRCA mutations....
SpeeDx Pty, Ltd. and MolGen announced the signing of an agreement to collaborate on supply and distribution of clinical diagnostics products and instrumentation across Europe and Asia Pacific. The partnership links specimen handling, nucleic acid extraction, assay set-up, amplification, and results reporting in a seamless integration of the companies technologies...
In the pharmaceutical industry, the trend is to move from conventional batch manufacturing to continuous manufacturing processes. The challenges for such change are numerous, but many papers are published to solve those issues and improve production. This is the case of the paper published by Carl Allenspach from Bristol-Myers Squibb (International Journal of Pharmaceutics 596 (2021)....
Owlstone Medical (or the “Company”), the global leader in Breath Biopsy® for applications in early disease detection and precision medicine, has announced the publication of a peer-reviewed study in Nature Scientific Reports. The paper investigates the performance of filters embedded in face masks for supporting the detection of SARS-CoV-2 as an alternative to nasopharyngeal swabs (NPS)...
Merck, a leading science and technology company, has announced the winners of this year’s Future Insight Prize. The € 1 million prize in the category of “Food Generation” was awarded during the Future Insight Days in Darmstadt, Germany, to Ting Lu, Professor of Bioengineering at the University of Illinois Urbana-Champaign, USA, and Stephen Techtmann, Associate Professor of Biological Sciences at Michigan Technological University, USA....
The race is on in the diagnostics industry to develop a device that instantly detects coronavirus for use in large public spaces and airports, according to one of the UK’s top medical technology recruiters. Ivor Campbell, chief executive of Snedden Campbell, said the biggest companies are chasing the ‘holy grail’ of a rapid-test, biosensing device – similar to that used to test blood sugar levels in diabetic patients – that will identify whether a patient has Covid within a matter of seconds...
Cerno Bioscience, in collaboration with XenoBiotic Labs*, has recently published an article in the peer reviewed journal "Rapid Communications in Mass Spectrometry" which demonstrates reliable and accurate quantitation of both cold and hot labeled compounds down to 0.5%. This robust method was tested on both simple and complex systems containing as many as 6 separate labeling sites and is capable of quantifying from...
MIMETAS, a leader in organ-on-chip-based disease models and technology, and Roche, a world-leading pharmaceutical company, announce that they have entered into a collaboration to develop human disease models to characterize novel compounds in inflammatory bowel disease (IBD) and hepatitis B virus infections (HBV). Under the terms of the agreement, MIMETAS is eligible to receive an upfront payment and milestone payments from Roche...
The Center of Excellence in Clinical Metabolomics, based on the UC Davis Sacramento campus, will enable targeted and untargeted metabolic profiling for large-scale population-based cohorts across translational research and precision medicine. The Center will develop standardized processes for the research community, including end-to-end metabolic profiling workflows; optimized liquid chromatography-mass spectrometry (LC-MS) methods, protocols...
Tumor fragments in the lab are able to predict whether the corresponding real-life patients will benefit from immunotherapy. “We’ve solved a major problem many scientists had been facing: preserving a tumors original composition and structure outside of the patient in the lab”, says cancer researcher Daniela Thommen from the Netherlands Cancer Institute. On 8 July, the results of her study are published in Nature Medicine....
VectorBuilder – a global leader in vector design, optimization and GMP manufacturing – has formed a worldwide strategic partnership with Univercells Technologies, a provider of novel biomanufacturing technologies for flexible and scalable viral vector production. VectorBuilder’s manufacturing center in Guangzhou, China, will work with Univercells Technologies to develop and optimize platform processes for the production of custom viral vectors for cell and gene therapies, as well as vaccine applications....
Illumina, Inc. has announced an agreement with the Belgian Genetic Centers to evaluate whole-genome sequencing (WGS) for the diagnosis of patients with intellectual disabilities (ID) and/or developmental disorders (DD) in routine care. The study, run by the Belgian Resolve Rare Diseases group (BeSolveRD), will also assess the health economic impact of WGS versus current standards of care....
Sinocompound Catalysts Co., Ltd has launched a new video series sharing its specialist catalyst expertise adding to its bank of educational materials. Titled ‘The essentials in a synthetic chemist’s toolbox’, the series was the idea and work of technical advisor, Dr Carin Seechurn. As a global provider of advanced homogeneous catalysts and ligands for pharmaceutical and fine chemical applications, Sinocompound is ideally placed to guide scientists through some of the challenges they may need to navigate...
A new study could lead to improved decision making in assigning treatments for children with the aggressive cancer rhabdomyosarcoma after revealing key genetic changes underlying development of the disease. In the largest and most comprehensive study of rhabdomyosarcoma to date, scientists found that specific genetic changes in tumours are linked to aggressiveness, early age of onset and location in the body....
The Government Chemist (GC), hosted at LGC, has published the results of a recent international ring trial on the determination of cannabidiol (CBD) - an uncontrolled cannabinoid- and controlled cannabinoids in consumer products such as food and cosmetics. Consumer CBD products have entered the UK market rapidly in a variety of forms, including food and cosmetics. CBD when used as an ingredient in food or cosmetic products must currently be free from controlled cannabinoids....
AMSBIO invite the global research community to the 2021 annual meeting of the ISSCR, the leading professional organization of stem cell scientists, to discover how iPSCs and organoids can be used in COVID-19 drug discovery research. At this virtual meeting - Dr. Kazuo Takayama from the renowned Center for iPS Cell Research and application (CiRA) at Kyoto University will be giving a unique insight into his recent pioneering research...
The Maulide Group at the University of Vienna (Austria) describe how a devastating water leak in a nearby chemistry laboratory prompted them to search for alternative, water-free, options to Liebig condensers for refluxing. The group teamed up with Green Labs Austria to see if they could provide and share a more sustainable solution to water cooled refluxing in the lab....
The moisture determination of liquid soap is essential to ensure a product of the highest quality. If the moisture content is too high or too low, this can result in a low quality product and wastage can occur. In this application note we determine the moisture of liquid soap using Precisa’s XM60/EM120 Halogen moisture analyser...
In 2021, Eppendorf AG, the Hamburg life sciences company, is presenting its highly prestigious research prize for the 26th time. The independent Eppendorf Award Jury chaired by Prof. Reinhard Jahn announced Dr. Tanmay Bharat, Sir William Dunn School of Pathology, University of Oxford, United Kingdom as the winner of the Eppendorf Award for European Investigators 2021....
108Labs, a biotechnology and software company with a mission to invent disruptive cellular agriculture projects, has announced their focus on building and programming the world’s first autonomous Cellufacturing® facility and artificial intelligence platform for the production of cell-cultured human milk, in the birthplace of biosynthetic human milk, Hillsborough, North Carolina....
Binding Site is pleased to announce that the ground-breaking iStopMM (Iceland Screens, Treats or Prevents Multiple Myeloma) study has reached an important milestone, with the publication of a paper outlining the design and recruitment of this population-based screening study. The large-scale study – which includes over 80,000 individuals, more than half of the eligible population of Iceland...
Leading Drug Discovery Contract Research Organisation Sygnature Discovery has announced the set-up of a state-of-the-art Early Candidate Developability Screening Group. Located at its headquarters in Nottingham, UK, the new service line will expand on the company’s offerings to customers by bridging into formal preclinical drug development and paving the way for clinical trials...
Scientists have identified a new class of targeted cancer drugs that offer the potential to treat patients whose tumours have faulty copies of the BRCA cancer genes. The drugs, known as POLQ inhibitors, specifically kill cancer cells with mutations in the BRCA genes while leaving healthy cells unharmed. And crucially, they can kill cancer cells that have become resistant to PARP inhibitors – an existing treatment for patients with BRCA mutations....